肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2013年
6期
385-388
,共4页
王新星%苗旺%王宏勤%刘晓东%范益民
王新星%苗旺%王宏勤%劉曉東%範益民
왕신성%묘왕%왕굉근%류효동%범익민
神经胶质瘤%p53上调凋亡调控因子%p53%细胞增殖%细胞凋亡
神經膠質瘤%p53上調凋亡調控因子%p53%細胞增殖%細胞凋亡
신경효질류%p53상조조망조공인자%p53%세포증식%세포조망
Glioma%p53-upregulated modulator of apoptosis%p53%Cell proliferation%Cell apoptosis
目的 观察p53上调凋亡调控因子(PUMA)对不同p53表型人类脑胶质瘤细胞系生长的影响,并探讨其可能的作用机制.方法 构建PUMA腺病毒(Ad-PUMA)及空载体腺病毒(Ad-DsRed),分别转染胶质瘤细胞系U251(p53突变型)及SHG-44(p53野生型),CCK-8法检测各组细胞增殖能力;流式细胞术检测各组细胞凋亡率;Western blot法检测PUMA及凋亡相关蛋白bcl-2、Bax的表达;Caspase 活性检测试剂盒检测Caspase-3、Caspase-8、Caspase-9的活性.结果 在p53状态不同的胶质瘤细胞系U251及SHG-44中,Ad-PUMA转染组与空载体组及空白对照组比较,均显现出细胞增殖抑制效应[抑制率分别为(50.89±4.73)%和(44.45±5.33)%,P< 0.05]以及促凋亡作用[凋亡率分别为(44.89±5.08)%和(31.67±7.32)%,P<0.05];Western blot结果显示,Ad-PUMA组胶质瘤细胞转染后,可见PUMA蛋白表达升高,同时伴随抗凋亡蛋白bcl-2表达降低及促凋亡蛋白Bax表达增强(P<0.05);Caspase活性检测结果显示Ad-PUMA组Caspase-3、Caspase-9活性增加(P<0.05),而Caspase-8活性未见明显改变(P> 0.05).结论 无论p53表型如何,PUMA均可抑制胶质瘤细胞增殖,促进其凋亡,其机制可能是通过线粒体凋亡途径即上调Bax,抑制bcl-2表达,进而激活Caspase-9实现的,Ad-PUMA有望成为胶质瘤基因治疗的新靶点.
目的 觀察p53上調凋亡調控因子(PUMA)對不同p53錶型人類腦膠質瘤細胞繫生長的影響,併探討其可能的作用機製.方法 構建PUMA腺病毒(Ad-PUMA)及空載體腺病毒(Ad-DsRed),分彆轉染膠質瘤細胞繫U251(p53突變型)及SHG-44(p53野生型),CCK-8法檢測各組細胞增殖能力;流式細胞術檢測各組細胞凋亡率;Western blot法檢測PUMA及凋亡相關蛋白bcl-2、Bax的錶達;Caspase 活性檢測試劑盒檢測Caspase-3、Caspase-8、Caspase-9的活性.結果 在p53狀態不同的膠質瘤細胞繫U251及SHG-44中,Ad-PUMA轉染組與空載體組及空白對照組比較,均顯現齣細胞增殖抑製效應[抑製率分彆為(50.89±4.73)%和(44.45±5.33)%,P< 0.05]以及促凋亡作用[凋亡率分彆為(44.89±5.08)%和(31.67±7.32)%,P<0.05];Western blot結果顯示,Ad-PUMA組膠質瘤細胞轉染後,可見PUMA蛋白錶達升高,同時伴隨抗凋亡蛋白bcl-2錶達降低及促凋亡蛋白Bax錶達增彊(P<0.05);Caspase活性檢測結果顯示Ad-PUMA組Caspase-3、Caspase-9活性增加(P<0.05),而Caspase-8活性未見明顯改變(P> 0.05).結論 無論p53錶型如何,PUMA均可抑製膠質瘤細胞增殖,促進其凋亡,其機製可能是通過線粒體凋亡途徑即上調Bax,抑製bcl-2錶達,進而激活Caspase-9實現的,Ad-PUMA有望成為膠質瘤基因治療的新靶點.
목적 관찰p53상조조망조공인자(PUMA)대불동p53표형인류뇌효질류세포계생장적영향,병탐토기가능적작용궤제.방법 구건PUMA선병독(Ad-PUMA)급공재체선병독(Ad-DsRed),분별전염효질류세포계U251(p53돌변형)급SHG-44(p53야생형),CCK-8법검측각조세포증식능력;류식세포술검측각조세포조망솔;Western blot법검측PUMA급조망상관단백bcl-2、Bax적표체;Caspase 활성검측시제합검측Caspase-3、Caspase-8、Caspase-9적활성.결과 재p53상태불동적효질류세포계U251급SHG-44중,Ad-PUMA전염조여공재체조급공백대조조비교,균현현출세포증식억제효응[억제솔분별위(50.89±4.73)%화(44.45±5.33)%,P< 0.05]이급촉조망작용[조망솔분별위(44.89±5.08)%화(31.67±7.32)%,P<0.05];Western blot결과현시,Ad-PUMA조효질류세포전염후,가견PUMA단백표체승고,동시반수항조망단백bcl-2표체강저급촉조망단백Bax표체증강(P<0.05);Caspase활성검측결과현시Ad-PUMA조Caspase-3、Caspase-9활성증가(P<0.05),이Caspase-8활성미견명현개변(P> 0.05).결론 무론p53표형여하,PUMA균가억제효질류세포증식,촉진기조망,기궤제가능시통과선립체조망도경즉상조Bax,억제bcl-2표체,진이격활Caspase-9실현적,Ad-PUMA유망성위효질류기인치료적신파점.
Objective To observe the influence of p53-upregulated modulator of apoptosis (PUMA) on the growth of human brain glioma cell lines U251 (p53 mutant) and SHG-44 (p53 wild type),and to explore its possible mechanism.Methods Construct the adenovirus PUMA (Ad-PUMA) and vector of adenovirus (AdDsRed) which were respectively transfected into glioma cell lines U251 and SHG-44.Cells proliferation rates were measured with cell counting kit-8 (CCK-8).The apoptotic ratios were detected by flow cytometry.The expression of PUMA and apoptosis associated proteins (bcl-2,Bax) were determined with Western blot analysis.Caspase-3,Caspase-8,Caspase-9 activity were measured by Caspase activity assay kit.Results Compared with vector group and blank control group,Ad-PUMA transfected group showed strong cell proliferating inhibition effects [the inhibition rates were (50.89±4.73) % and (44.45±5.33) % respectively,P <0.05] and pro-apoptotic effects [apoptotic rates were (44.89±5.08) % and (31.67±7.32) %,P < 0.05] in different p53 glioma cell lines U251 and SHG-44.Western blot analysis showed that PUMA protein expression increased after Ad-PUMA transfection,accompanied by the reduced expression of the anti-apoptotic protein bcl-2 and the increased expression of pro-apoptotic protein Bax.The activity of Caspase testing results showed that the Caspase-3,Caspase-9 activity increased significantly,while the Caspase-8 activity changed little.Conclusion No matter how p53 phenotype,PUMA can inhibit glioma proliferation,promote apoptosis,and its mechanism may be through the mitochondrial apoptotic pathways,upregulation of Bax and inhibition of bcl-2 expression,which activated Caspase-9.Ad-PUMA is expected to become a new target for gene therapy of gliomas.